Epidemiogy and treatment of tuberculosis in Switzerland;Epidémiologie et prise en charge de la tuberculose en Suisse

Revue Medicale Suisse

Volumn 2, Issue 82, 2006, Pages 2276-2281

  Helbling, Peter ^a   Zellweger, Jean Pierre ^b   Altpeter, Ekkehardt ^a   Boubaker, Karim ^a  

^a Division Prévention des Dangers   (Switzerland)

^b Ligue Pulmonaire Suisse ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANAMNESIS; DISEASE COURSE; DISEASE TRANSMISSION; EMERGENCY CARE; FOLLOW UP; HUMAN; INFECTION RISK; MEDICAL SOCIETY; MICROSCOPY; PATIENT CARE; REVIEW; SCREENING; SMEAR; SOCIAL ASPECT; SPUTUM EXAMINATION; SWITZERLAND; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MIDDLE AGED; SWITZERLAND; TUBERCULOSIS, PULMONARY;

EID: 33750938115     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. WHO. Global tuberculosis control: Surveillance, planning, financing. WHO report 2006. 2006; WHO/HTM/TB/2006.362.
2. Rieder HL. Elévation de l'âge médian de la tuberculose. Bulletin OFSP 2000;n° 7:144-5.
3. OFSP. La tuberculose en Suisse de 2001 à 2004. Bulletin OFSP 2006;22:428-33.
4. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world:Third global report 1999-2002; 2004.
5. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
6. Helbling P, Altpeter E, Raeber PA, Pfyffer GE, Zellweger JP. Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: The central link. Eur Respir J 2000;16:200-2.
7. Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe:A systematic review. Thorax 2006;61:158-63.
8. Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis:A critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004;8:278-85.
9. Tueller C, Chhajed PN, Buitrago-Tellez C, et al. Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis. Eur Respir J 2005;26:767-72.
10. Chen NH, Liu YC, Tsao TC, et al. Combined bronchoalveolar lavage and polymerase chain reaction in the diagnosis of pulmonary tuberculosis in smear-negative patients. Int J Tuberc Lung Dis 2002;6:350-5.
11. Al Zahrani K, Al Jahdali H, Poirier L, Rene P, Menzies D. Yield of smear, culture and amplification tests from repeated sputum induction for the diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 2001;5:855-60.
12. Broekmans JF, Migliori GB, Rieder HU et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. Eur Respir J 2002;19:765-75.
13. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB. Tuberculosis control in Europe and international migration. Eur Respir J 1994;7:1545-53.
14. OFSP, Rieder HL. Requérants d'asile et dépistage de la tuberculose active. Bulletin OFSP 2006;1:9-11.
15. OFSP. Réorientation des mesures sanitaires de frontière. Bulletin OFSP 2006;1:14-6.
16. OFSP. Dépistage de la tuberculose chez les requérants d'asile de 2000 à 2003. Bulletin OFSP 2006;1:12-3.
17. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005;9:1183-203.
18. Helbling P, Medinger C, Altpeter E, et al. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly 2002;132:517-22.